The genetics and biology of Irf5-mediated signaling in lupus

Autoimmunity

Volumn 40, Issue 8, 2007, Pages 591-601

  Kozyrev, Sergey V ^a   Alarcon Riquelme, Marta E ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Autoimmune disease; Haplotype; Interferon ; Interferon regulatory factor 5; Systemic lupus erythematosus; Toll like receptors

Indexed keywords

ALPHA INTERFERON; INTERFERON RESPONSIVE FACTOR 5; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BINDING SITE; DISEASE PREDISPOSITION; EXON; GENE ACTIVATION; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE IDENTIFICATION; GENE INSERTION; GENE MAPPING; GENE TARGETING; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENETICS; HAPLOTYPE; HUMAN; NEOPLASM; NUCLEOTIDE SEQUENCE; RACE DIFFERENCE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ALTERNATIVE SPLICING; ANIMALS; EXONS; HUMANS; INTERFERON REGULATORY FACTORS; INTERFERON-ALPHA; LEUKOCYTES; LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYMORPHISM, GENETIC; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION;

EID: 37349039478     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930701510905     Document Type: Article

References (93)

1. Platanias, LC (2005) Mechanisms of type-I- and type-II-interferon-mediated signaling. Nat Rev Immunol, 5, pp. 375-386.
2. Ronnblom, L., Ramstedt, U. and Alm, GV (1983) Properties of human natural interferon-producing cells stimulated by tumor cell lines. Eur J Immunol, 13, pp. 471-476.
3. Ronnblom, L. and Alm, GV (2002) The natural interferon-alpha producing cells in systemic lupus erythematosus. Hum Immunol, 63, pp. 1181-1193.
4. Kadowaki, N., Ho, S., Antonenko, S., Malefyt, RW, Kastelein, RA, Bazan, F. and Liu, YJ (2001) Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med, 194, pp. 863-869.
5. Arnheiter, H., Skuntz, S., Noteborn, M., Chang, S. and Meier, E. (1990) Transgenic mice with intracellular immunity to influenza virus. Cell, 62, pp. 51-61.
6. Pavlovic, J., Schroder, A., Blank, A., Pitossi, F. and Staeheli, P. (1993) Mx proteins: GTPases involved in the interferon-induced antiviral state. Ciba Found Symp, 176, pp. 233-243.
7. Stark, GR, Kerr, IM, Williams, BR, Silverman, RH and Schreiber, RD (1998) How cells respond to interferons. Annu Rev Biochem, 67, pp. 227-264.
8. Kato, H., Sato, S., Yoneyama, M., Yamamoto, M., Uematsu, S., Matsui, K., Tsujimura, T., Takeda, K., Fujita, T., Takeuchi, O. and Akira, S. (2005) Cell type-specific involvement of RIG-I in antiviral response. Immunity, 23, pp. 19-28.
9. Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T., Ishii, KJ, Yamaguchi, O., Otsu, K., Tsujimura, T., Koh, CS, Reis, C., Sousa, e., Matsuura, Y., Fujita, T. and Akira, S. (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature, 441, pp. 101-105.
10. Blanco, P., Palucka, AK, Gill, M., Pascual, V. and Banchereau, J. (2001) Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science, 294, pp. 1540-1543.
11. Honda, K., Sakaguchi, S., Nakajima, C., Watanabe, A., Yanai, H., Matsumoto, M., Ohteki, T., Kaisho, T., Takaoka, A., Akira, S., Seya, T. and Taniguchi, T. (2003) Selective contribution of IFN-alpha/beta signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection. Proc Natl Acad Sci USA, 100, pp. 10872-10877.
12. Gottenberg, JE, Cagnard, N., Lucchesi, C., Letourneur, F., Mistou, S., Lazure, T., Jacques, S., Ba, N., Ittah, M., Lepajolec, C., Labetoulle, M., Ardizzone, M., Sibilia, J., Fournier, C., Chiocchia, G. and Mariette, X. (2006) Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome. Proc Natl Acad Sci USA, 103, pp. 2770-2775.
13. Sharara, AI, Perkins, DJ, Misukonis, MA, Chan, SU, Dominitz, JA and Weinberg, JB (1997) Interferon (IFN)-alpha activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: Possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-alpha in vivo. J Exp Med, 186, pp. 1495-1502.
14. Bon, A Le, Etchart, N., Rossmann, C., Ashton, M., Hou, S., Gewert, D., Borrow, P. and Tough, DF (2003) Cross-priming of CD8+T-cells stimulated by virus-induced type I interferon. Nat Immunol, 4, pp. 1009-1015.
15. Marrack, P., Kappler, J. and Mitchell, T. (1999) Type I interferons keep activated T-cells alive. J Exp Med, 189, pp. 521-530.
16. Jego, G., Palucka, AK, Blanck, JP, Chalouni, C., Pascual, V. and Banchereau, J. (2003) Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity, 19, pp. 225-234.
17. Braun, D., Caramalho, I. and Demengeot, J. (2002) IFN-alpha/beta enhances BCR-dependent B-cell responses. Int Immunol, 14, pp. 411-419.
18. Bon, A Le, Schiavoni, G., D'Agostino, G., Gresser, I., Belardelli, F. and Tough, DF (2001) Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity, 14, pp. 461-470.
19. Parmar, S. and Platanias, LC (2003) Interferons: Mechanisms of action and clinical applications. Curr Opin Oncol, 15, pp. 431-439.
20. Brassard, DL, Grace, MJ and Bordens, RW (2002) Interferon-alpha as an immunotherapeutic protein. J Leukoc Biol, 71, pp. 565-581.
21. Malik, AH and Lee, WM (2000) Chronic hepatitis B virus infection: Treatment strategies for the next millennium. Ann Intern Med, 132, pp. 723-731.
22. Liang, TJ, Rehermann, B., Seeff, LB and Hoofnagle, JH (2000) Pathogenesis, natural history, treatment and prevention of hepatitis C. Ann Intern Med, 132, pp. 296-305.
23. Nguyen, MH and Wright, TL (2001) Therapeutic advances in the management of hepatitis B and hepatitis C. Curr Opin Infect Dis, 14, pp. 593-601.
24. Ronnblom, LE, Alm, GV and Oberg, KE (1991) Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med, 115, pp. 178-183.
25. Ioannou, Y. and Isenberg, DA (2000) Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis Rheum, 43, pp. 1431-1442.
26. Raanani, P. and Ben-Bassat, I. (2002) Immune-mediated complications during interferon therapy in hematological patients. Acta Haematol, 107, pp. 133-144.
27. Baechler, EC, Batliwalla, FM, Reed, AM, Peterson, EJ, Gaffney, PM, Moser, KL, Gregersen, PK and Behrens, TW (2006) Gene expression profiling in human autoimmunity. Immunol Rev, 210, pp. 120-137.
28. Bengtsson, AA, Sturfelt, G., Truedsson, L., Blomberg, J., Alm, G., Vallin, H. and Ronnblom, L. (2000) Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus, 9, pp. 664-671.
29. Kanayama, Y., Kim, T., Inariba, H., Negoro, N., Okamura, M., Takeda, T. and Inoue, T. (1989) Possible involvement of interferon alfa in the pathogenesis of fever in systemic lupus erythematosus. Ann Rheum Dis, 48, pp. 861-863.
30. Ronnblom, L. and Alm, GV (2001) An etiopathogenic role for the type I IFN system in SLE. Trends Immunol, 22, pp. 427-431.
31. Pascual, V., Banchereau, J. and Palucka, AK (2003) The central role of dendritic cells and interferon-alpha in SLE. Curr Opin Rheumatol, 15, pp. 548-556.
32. Sigurdsson, S., Nordmark, G., Goring, HH, Lindroos, K., Wiman, AC, Sturfelt, G., Jonsen, A., Rantapaa-Dahlqvist, S., Moller, B., Kere, J., Koskenmies, S., Widen, E., Eloranta, ML, Julkunen, H., Kristjansdottir, H., Steinsson, K., Alm, G., Ronnblom, L. and Syvanen, AC (2005) Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet, 76, pp. 528-537.
33. Graham, RR, Kozyrev, SV, Baechler, EC, Reddy, MV, Plenge, RM, Bauer, JW, Ortmann, WA, Koeuth, T., Escribano, MF Gonzalez, Argentine and Spanish Collaborative Groups, Pons-Estel, B., Petri, M., Daly, M., Gregersen, PK, Martin, J., Altshuler, D., Behrens, TW and Alarcon-Riquelme, ME (2006) A common haplotype of interferon regulatory factor 5(IRF5) requlates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet, 38, pp. 550-555.
34. Cheung, VG, Spielman, RS, Ewens, KG, Weber, TM, Morley, M. and Burdick, JT (2005) Mapping determinants of human gene expression by regional and genome-wide association. Nature, 437, pp. 1365-1369.
35. Demirci, FY, Manzi, S., Ramsey-Goldman, R., Minster, RL, Kenney, M., Shaw, PS, Dunlop-Thomas, CM, Kao, AH, Rhew, E., Bontempo, F., Kammerer, C. and Kamboh, MI (2007) Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE). Ann Hum Genet, 71, pp. 308-311.
36. Graham, DS, Manku, H., Wagner, S., Reid, J., Timms, K., Gutin, A., Lanchbury, JS and Vyse, TJ (2007) Association of IRF5 in UK SLE families identifies a variant involved in polyadenylation. Hum Mol Genet, 16, pp. 579-591.
37. Alarcon-Segovia, D. (2004) Shared autoimmunity: The time has come. Curr Rheumatol Rep, 6, pp. 171-174.
38. Rueda, B., Reddy, MV, Gonzalez-Gay, MA, Balsa, A., Pascual-Salcedo, D., Petersson, IF, Eimon, A., Paira, S., Scherbarth, HR, Pons-Estel, BA, Gonzalez-Escribano, MF, Alarcon-Riquelme, ME and Martin, J. (2006) Analysis of IRF5 gene functional polymorphisms in rheumatoid arthritis. Arthritis Rheum, 54, pp. 3815-3819.
39. Garnier, S., Dieude, P., Michou, L., Barbet, S., Tan, A., Lasbleiz, S., Bardin, T., Prum, B. and Cornelis, F. (2007) The systemic lupus erythematosus new genetic factor IRF5 rs2004640-T allele is not linked to, nor associated with rheumatoid arthritis, in a family-based study from the French caucasian population. Ann Rheum Dis, 66, pp. 828-831.
40. Barnes, BJ, Moore, PA and Pitha, PM (2001) Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes. J Biol Chem, 276, pp. 23382-23390.
41. Hayashida, S., Yamasaki, K., Asada, Y., Soeda, E., Niikawa, N. and Kishino, T. (2000) Construction of a physical and transcript map flanking the imprinted MEST/PEG1 region at 7q32. Genomics, 66, pp. 221-225.
42. Lu, R., Au, WC, Yeow, WS, Hageman, N. and Pitha, PM (2000) Regulation of the promoter activity of interferon regulatory factor-7 gene. J Biol Chem, 275, pp. 31805-31812.
43. Barnes, BJ, Kellum, MJ, Pinder, KE, Frisancho, JA and Pitha, PM (2003) Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death. Cancer Res, 63, pp. 6424-6431.
44. Mancl, ME, Hu, G., Sangster-Guity, N., Olshalsky, SL, Hoops, K., Fitzgerald-Bocarsly, P., Pitha, PM, Pinder, K. and Barnes, BJ (2005) Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms. Multiple isoforms with distinct cell type-specific expression, localization, regulation, and function. J Biol Chem, 280, pp. 21078-21090.
45. Rogers, S., Wells, R. and Rechsteiner, M. (1986) Amino acid sequences common to rapidly degraded proteins: The PEST hypothesis. Science, 234, pp. 364-368.
46. Rechsteiner, M. and Rogers, SW (1996) PEST sequences and regulation by proteolysis. Trends Biochem Sci, 21, pp. 267-271.
47. Khabar, KSA (2005) The AU-rich transcriptome: More than interferons and cytokines, and its role in disease. J. Interferon Cytokine Res., 25, pp. 1-10.
48. Clark, AR, Dean, JL and Saklatvala, J. (2003) Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38. FEBS Lett, 546, pp. 37-44.
49. Jacob, CO, Lee, SK and Strassmann, G. (1996) Mutational analysis of TNF-alpha gene reveals a regulatory role for the 3'-untranslated region in the genetic predisposition to lupus-like autoimmune disease. J Immunol, 156, pp. 3043-3050.
50. Kontoyiannis, D., Pasparakis, M., Pizarro, TT, Cominelli, F. and Kollias, G. (1999) Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies. Immunity, 10, pp. 387-398.
51. Barnes, BJ, Kellum, MJ, Field, AE and Pitha, PM (2002) Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes. Mol Cell Biol, 22, pp. 5721-5740.
52. Lin, R., Yang, L., Arguello, M., Penafuerte, C. and Hiscott, J. (2005) A CRM1-dependent nuclear export pathway is involved in the regulation of IRF-5 subcellular localization. J Biol Chem, 280, pp. 3088-3095.
53. Lin, R., Heylbroeck, C., Pitha, PM and Hiscott, J. (1998) Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol, 18, pp. 2986-2996.
54. Yoneyama, M., Suhara, W., Fukuhara, Y., Fukuda, M., Nishida, E. and Fujita, T. (1998) Direct triggering of the type I interferon system by virus infection: Activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J, 17, pp. 1087-1095.
55. Kumar, KP, McBride, KM, Weaver, BK, Dingwall, C. and Reich, NC (2000) Regulated nuclear-cytoplasmic localization of interferon regulatory factor 3, a subunit of double-stranded RNA-activated factor 1. Mol Cell Biol, 20, pp. 4159-4168.
56. Cheng, TF, Brzostek, S., Ando, O., Van Scoy, S., Kumar, KP and Reich, NC (2006) Differential activation of IFN regulatory factor (IRF)-3 and IRF-5 transcription factors during viral infection. J Immunol, 176, pp. 7462-7470.
57. Barnes, BJ, Field, AE and Pitha-Rowe, PM (2003) Virus-induced heterodimer formation between IRF-5 and IRF-7 modulates assembly of the IFNA enhanceosome in vivo and transcriptional activity of IFNA genes. J Biol Chem, 278, pp. 16630-16641.
58. Takeda, K. and Akira, S. (2005) Toll-like receptors in innate immunity. Int Immunol, 17, pp. 1-14.
59. Iwasaki, A. and Medzhitov, R. (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol, 5, pp. 987-995.
60. O'Neill, LA (2006) How Toll-like receptors signal: What we know and what we don't know. Curr Opin Immunol, 18, pp. 3-9.
61. Honda, K. and Taniguchi, T. (2006) Toll-like receptor signaling and IRF transcription factors. IUBMB Life, 58, pp. 290-295.
62. Honda, K. and Taniguchi, T. (2006) IRFs: Master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol, 6, pp. 644-658.
63. Takaoka, A., Yanai, H., Kondo, S., Duncan, G., Negishi, H., Mizutani, T., Kano, S., Honda, K., Ohba, Y., Mak, TW and Taniguchi, T. (2005) Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature, 434, pp. 243-249.
64. Negishi, H., Ohba, Y., Yanai, H., Takaoka, A., Honma, K., Yui, K., Matsuyama, T., Taniguchi, T. and Honda, K. (2005) Negative regulation of Toll-like-receptor signaling by IRF-4. Proc Natl Acad Sci USA, 102, pp. 15989-15994.
65. Schoenemeyer, A., Barnes, BJ, Mancl, ME, Latz, E., Goutagny, N., Pitha, PM, Fitzgerald, KA and Golenbock, DT (2005) The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling. J Biol Chem, 280, pp. 17005-17012.
66. Izaguirre, A., Barnes, BJ, Amrute, S., Yeow, WS, Megjugorac, N., Dai, J., Feng, D., Chung, E., Pitha, PM and Fitzgerald-Bocarsly, P. (2003) Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells. J Leukoc Biol, 74, pp. 1125-1138.
67. Jarrossay, D., Napolitani, G., Colonna, M., Sallusto, F. and Lanzavecchia, A. (2001) Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol, 31, pp. 3388-3393.
68. Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N. and Taniguchi, T. (2005) IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature, 434, pp. 772-777.
69. Honda, K., Ohba, Y., Yanai, H., Negishi, H., Mizutani, T., Takaoka, A., Taya, C. and Taniguchi, T. (2005) Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature, 434, pp. 1035-1040.
70. Barnes, BJ, Richards, J., Mancl, M., Hanash, S., Beretta, L. and Pitha, PM (2004) Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection. J Biol Chem, 279, pp. 45194-45207.
71. Gerard, C. and Rollins, BJ (2001) Chemokines and disease. Nat Immunol, 2, pp. 108-115.
72. Nishimoto, N. and Kishimoto, T. (2006) Interleukin 6: From bench to bedside. Nat Clin Pract Rheumatol, 2, pp. 619-626.
73. Garcia-Carrasco, M., Fuentes-Alexandro, S., Escarcega, RO, Salgado, G. and Riebeling, C. (2006) Cervera R pathophysiology of sjogren's syndrome. Arch Med Res, 37, pp. 921-932.
74. Tak, PP (2006) Chemokine inhibition in inflammatory arthritis. Best Pract Res Clin Rheumatol, 20, pp. 929-939.
75. Connell, L. and McInnes, IB (2006) New cytokine targets in inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol, 20, pp. 865-878.
76. Bauer, JW, Baechler, EC, Petri, M., Batliwalla, FM, Crawford, D., Ortmann, WA, Espe, KJ, Li, W., Patel, DD, Gregersen, PK and Behrens, TW (2006) Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus. PLoS Med, 3, p. e491.
77. Emlen, W., Niebur, J. and Kadera, R. (1994) Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol, 152, pp. 3685-3692.
78. Ren, Y., Tang, J., Mok, MY, Chan, AW, Wu, A. and Lau, CS (2003) Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum, 48, pp. 2888-2897.
79. Grondal, G., Traustadottir, KH, Kristjansdottir, H., Lundberg, I., Klareskog, L., Erlendsson, K. and Steinsson, K. (2002) Increased T-lymphocyte apoptosis/necrosis and IL-10 producing cells in patients and their spouses in Icelandic systemic lupus erythematosus multicase families. Lupus, 11, pp. 435-442.
80. Riemekasten, G. and Hahn, BH (2005) Key autoantigens in SLE. Rheumatology (Oxford), 44, pp. 975-982.
81. Kaplan, MJ (2004) Apoptosis in systemic lupus erythematosus. Clin Immunol, 112, pp. 210-218.
82. Arbuckle, MR, James, JA, Kohlhase, KF, Rubertone, MV, Dennis, GJ and Harley, JB (2001) Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus. Scand J Immunol, 54, pp. 211-219.
83. Rovere, P., Vallinoto, C., Bondanza, A., Crosti, MC, Rescigno, M., Ricciardi-Castagnoli, P., Rugarli, C. and Manfredi, AA (1998) Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J Immunol, 161, pp. 4467-4471.
84. Miwa, K., Asano, M., Horai, R., Iwakura, Y., Nagata, S. and Suda, T. (1998) Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand. Nat Med, 4, pp. 1287-1292.
85. Rovere, P., Sabbadini, MG, Fazzini, F., Bondanza, A., Zimmermann, VS, Rugarli, C. and Manfredi, AA (2000) Remnants of suicidal cells fostering systemic autoaggression. Apoptosis in the origin and maintenance of autoimmunity. Arthritis Rheum, 43, pp. 1663-1672.
86. Tanaka, N., Ishihara, M., Lamphier, MS, Nozawa, H., Matsuyama, T., Mak, TW, Aizawa, S., Tokino, T., Oren, M. and Taniguchi, T. (1996) Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature, 382, pp. 816-818.
87. Taniguchi, T., Lamphier, MS and Tanaka, N. (1997) IRF-1: The transcription factor linking the interferon response and oncogenesis. Biochim Biophys Acta, 1333, p. M9.
88. Hao, SX and Ren, R. (2000) Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder. Mol Cell Biol, 20, pp. 1149-1161.
89. Heylbroeck, C., Balachandran, S., Servant, MJ, DeLuca, C., Barber, GN, Lin, R. and Hiscott, J. (2000) The IRF-3 transcription factor mediates Sendai virus-induced apoptosis. J Virol, 74, pp. 3781-3792.
90. Mori, T., Anazawa, Y., Iiizumi, M., Fukuda, S., Nakamura, Y. and Arakawa, H. (2002) Identification of the interferon regulatory factor 5 gene (IRF-5) as a direct target for p53. Oncogene, 21, pp. 2914-2918.
91. Lin, R., Heylbroeck, C., Pitha, PM and Hiscott, J. (1998) Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol, 18, pp. 2986-2996.
92. Lin, R., Mamane, Y. and Hiscott, J. (1999) Structural and functional analysis of interferon regulatory factor 3: Localization of the transactivation and autoinhibitory domains. Mol Cell Biol, 19, pp. 2465-2474.
93. Kokkinakis, DM, Liu, X., Chada, S., Ahmed, MM, Shareef, MM, Singha, UK, Yang, S. and Luo, J. (2004) Modulation of gene expression in human central nervous system tumors under methionine deprivation-induced stress. Cancer Res, 64, pp. 7513-7525.